Frontiers in Immunology | Cancer Immunity and Immunotherapy

Systematic Review

Published on 09 Aug 2023

Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Wei Zhang
Yifei Tan
Yuquan Li
Jiang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1234142

6,470 views
25 citations

Original Research

Published on 09 Aug 2023

Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models

in Cancer Immunity and Immunotherapy

Emile J. Clappaert
Daliya Kancheva
Jan Brughmans
Ayla Debraekeleer
Pauline M. R. Bardet
Yvon Elkrim
Dagmar Lacroix
Maida Živalj
Ahmed E.I. Hamouda
Jo A. Van Ginderachter

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166180

6,494 views
5 citations

Original Research

Published on 09 Aug 2023

Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period

in Cancer Immunity and Immunotherapy

Huageng Huang
Yuyi Yao
Xinyi Deng
Huawei Weng
Zegeng Chen
Le Yu
Zhao Wang
Xiaojie Fang
Huangming Hong
He Huang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1195659

2,205 views
3 citations

Original Research

Published on 09 Aug 2023

Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yuxin Wang
Xueshuai Wan
Shunda Du

Frontiers in Immunology

doi 10.3389/fimmu.2023.1100100

4,563 views
4 citations

Original Research

Published on 09 Aug 2023

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Wentao Zhang
Haizeng Qu
Xiaoqing Ma
Liang Li
Yanjun Wei
Ye Wang
Renya Zeng
Yuanliu Nie
Chenggui Zhang
Ke Yin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1179742

12,919 views
9 citations

Original Research

Published on 09 Aug 2023

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab

in Cancer Immunity and Immunotherapy

Chen Lyu
Birgit Stadlbauer
Lili Wang
Alexander Buchner
Heike Pohla

Frontiers in Immunology

doi 10.3389/fimmu.2023.1186388

3,090 views
4 citations

Systematic Review

Published on 08 Aug 2023

The benefit and risk of PD-1/PD-L1 inhibitors plus anti-angiogenic agents as second or later-line treatment for patients with advanced non-small-cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials

in Cancer Immunity and Immunotherapy

Shubin Chen
Wanying Mo
Wei Jiang
Shaozhang Zhou
Haijie Gan
Qitao Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1218258

4,847 views
7 citations

Editorial

Published on 07 Aug 2023

Editorial: Bone metastasis in the milieu of osteoimmunology

in Cancer Immunity and Immunotherapy

Gunjan Sharma
Marco Ponzetti
Jawed A. Siddiqui

Frontiers in Immunology

doi 10.3389/fimmu.2023.1265434

1,718 views

Original Research

Published on 04 Aug 2023

Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response

in Cancer Immunity and Immunotherapy

Andrea Aran
Gonzalo Lázaro
Vicente Marco
Elisa Molina
Ferran Abancó
Vicente Peg
María Gión
Laia Garrigós
José Pérez-García
Javier Cortés

Frontiers in Immunology

doi 10.3389/fimmu.2023.1227766

3,400 views
6 citations

Review

Published on 04 Aug 2023

The off-target effects of AID in carcinogenesis

in Cancer Immunity and Immunotherapy

Junna Jiao
Zhuangwei Lv
Yurong Wang
Liye Fan
Angang Yang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1221528

5,096 views
6 citations

Original Research

Published on 04 Aug 2023

Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma

in Cancer Immunity and Immunotherapy

Hong Phuong Nguyen
Anh Quynh Le
Enze Liu
Annamaria Cesarano
Francesco DiMeo
Fabiana Perna
Reuben Kapur
Brian A. Walker
Ngoc Tung Tran

Frontiers in Immunology

doi 10.3389/fimmu.2023.1239614

5,076 views
7 citations

Review

Published on 04 Aug 2023

Bibliometric study of immunotherapy for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Zhiyi Li
Ying Zhang
Baipan Zhang
Rui Guo
Minhua He
Zi-Ling Liu
Lei Yang
Hong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1210802

12,058 views
14 citations

Review

Published on 04 Aug 2023

Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy

in Cancer Immunity and Immunotherapy

Zhuangzhuang Zheng
Jing Su
Xueying Bao
Huanhuan Wang
Chenbin Bian
Qin Zhao
Xin Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1247268

9,999 views
48 citations

Original Research

Published on 03 Aug 2023

Identifying cancer-associated leukocyte profiles using high-resolution flow cytometry screening and machine learning

in Cancer Immunity and Immunotherapy

David A. Simon Davis
Melissa Ritchie
Dillon Hammill
Jessica Garrett
Robert O. Slater
Naomi Otoo
Anna Orlov
Katharine Gosling
Jason Price
Desmond Yip

Frontiers in Immunology

doi 10.3389/fimmu.2023.1211064

3,530 views

Review

Published on 03 Aug 2023

Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations

in Cancer Immunity and Immunotherapy

Jeremy D. Rubinstein
Maureen M. O’Brien

Frontiers in Immunology

doi 10.3389/fimmu.2023.1237738

13,117 views
12 citations

Case Report

Published on 03 Aug 2023

Case Report: Cadonilimab-related toxic epidermal necrolysis-like reactions successfully treated with supplemental Adalimumab

in Cancer Immunity and Immunotherapy

Peng-Yu Chen
Zi-Yun Li
Sui-Qing Cai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188523

4,293 views
6 citations